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Abstract
Background: The Institute of Medicine report “Relieving Pain in America” recommends the promotion of
patient self-management of pain for all people with pain. Given the high prevalence of chronic pain in the
US, new strategies are needed to enhance access to cognitive behavioral therapy (CBT) and other evidence-
based treatments designed to facilitate self-management of chronic pain conditions. Although CBT is efficacious, many
patients have limited or no access to CBT. Technology-assisted delivery of CBT may improve access while maintaining
efficacy.
Methods/Design: We describe a randomized non-inferiority trial of interactive voice response (IVR)-based CBT for
patients with chronic low back pain. This intervention uses daily IVR monitoring and weekly pre-recorded therapist
feedback, based on patient-reported information, to provide treatment for patients at home. A total of 230 patients
with chronic low back pain are being identified from a single statewide health system serving US military veterans.
Participants are randomized to receive either ten weeks of in-person CBT or IVR-based CBT. The primary outcome is
pain intensity as measured by the Numeric Rating Scale immediately post-treatment. Secondary outcomes include
pain-related interference, emotional functioning, and quality of life measured immediately post treatment, and 6
and 9 months post recruitment. Exploratory objectives of the study are to examine: (1) potential mediators of impact
on clinical outcomes (treatment retention, self-reported skill practice ratings, IVR call adherence, and treatment
satisfaction); and (2) moderators of treatment engagement, adherence to therapist recommendations for pain
coping skill practice, and effects on clinical outcomes.
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Discussion: This non-inferiority trial may identify an alternative to resource intensive in-person CBT that
allows many more patients to receive care while also increasing retention of those enrolled in the program.
Trial registration: ClinicalTrials.gov: NCT01025752. Registered 3 December 2009.
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Background
Need for pain self-management
A recent Institute of Medicine (IOM) report estimates
that approximately 100 million people in the US experi-
ence chronic pain at any one point in time [1]. Among
the IOM committee’s recommendations is the widespread
promotion of pain self-management for all people who ex-
perience pain. The report highlights the frequent barriers
to care experienced by individuals with pain and encour-
ages the development of strategies to address those bar-
riers. Directly relevant to these two recommendations are
investigations of novel ways to provide access to evidence-
based self-management interventions. Although many in-
terventions exist and individuals with pain may have a var-
iety of preferences, cognitive behavioral therapy (CBT) is a
mainstay of pain self-management interventions.
Chronic pain and CBT
CBT has demonstrated efficacy for reducing pain and
improving function in individuals with chronic pain. In a
meta-analysis of psychological interventions for CLBP,
Kerns and colleagues documented moderate to large ef-
fects of CBT and other psychological interventions in re-
ducing pain and pain-related interference [2]. Similarly,
a Cochrane review found combined cognitive and
relaxation-based treatments were superior to a wait list
control condition and resulted in moderate reductions
in pain intensity [3].
The overarching goal of CBT is to assist the patient in
developing an adaptive problem-solving, self-management
approach to pain based on a conceptualization of pain as
controllable and a personal attitude of self-efficacy and
self-control. An important aspect of CBT is its foundation
in a biopsychosocial and multidimensional perspective of
chronic pain and the fact that CBT is specifically designed
to target reductions in pain, disability, and emotional
distress, while improving the patient’s overall quality of
life. During therapy, a range of cognitive (e.g., attention
diversion, development of coping self-statements) and
behavioral (e.g., behavioral activation, activity pacing,
relaxation) pain coping skills are taught. Patients are
encouraged to practice the skills outside treatment ses-
sions through assignment of specific goals for pain coping
skill practice. Goal setting and coping skill practice are
important components of CBT. Therapist reinforcement
of pain coping skill practice, goal accomplishment, and
problem solving, and support when goals are not success-
fully obtained are also important aspects of treatment.
Although CBT is an effective treatment for reducing
pain and enhancing physical and emotional functioning,
it has several features that have limited its availability in
practice. A typical CBT treatment schedule may require
weekly, 50-minute sessions for 6 to 12 weeks. This
schedule can put treatment out of reach for patients
with limited funds or transportation options, as well as
for patients with health and mobility limitations or com-
peting demands that do not easily accommodate weekly
appointments. Trained therapists are often unavailable,
especially in rural areas, low -income communities, or
health systems that are far removed from academic med-
ical centers [4]. As a consequence, CBT therapists only
serve a small proportion of patients who might benefit
[5]. As a partial solution to these access and cost bar-
riers, new approaches look to mobile health technology,
such as interactive voice response, as a way to increase
the scale of sustainable programs for patients without
the need for 1–1 in-person encounters.
Interactive Voice Response (IVR)
IVR is an automated telephonic technology that allows
patients to report and receive information via their mo-
bile or landline telephone. Calls can be placed at times
that are convenient to the patient, and data are collected
when patients answer pre-recorded voice prompts using
their telephone key pad or voice. Patients also can re-
ceive information via IVR such as pre-recorded didactic
information regarding pain coping skills or personalized
therapist feedback. The therapist is able to monitor a pa-
tient’s daily IVR reports and tailor subsequent feedback
based on pain-related symptoms, treatment engagement
or treatment adherence.
Use of IVR to deliver treatment
There is emerging evidence that IVR-based interventions
are effective for providing education, peer support, and
tailored messages to enhance adherence and maintain
treatment gains for patients with chronic health condi-
tions [6–10]. Reviews of the broader literature of
technology-assisted interventions beyond IVR for condi-
tions like depression and anxiety have concluded that,
although technology-assisted interventions are effica-
cious, some form of therapist contact enhances not just
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treatment effects, but also treatment retention [11–13].
Within the realm of pain-related research, Naylor and
colleagues found that the use of IVR after in-person
CBT to reinforce the use of pain coping skills can main-
tain and even enhance gains made in treatment, redu-
cing the use of opioid-based pharmacotherapy [8, 9, 14].
Also, studies have shown high levels of adherence to
daily IVR telephone calls whether participants received
payments for calls or not [6, 14]. Despite these promis-
ing results, to our knowledge there have been no trials
of a solely IVR-based treatment for chronic pain.
Conceptual framework
Non-inferiority trial of IVR-based CBT for chronic pain
When a new treatment promises potential benefits such
as improved access, fewer side effects, or lower cost rela-
tive to an established treatment, but there is no hypothe-
sized reason to believe that the new treatment is more
efficacious, a non-inferiority trial can be used to examine
the relative benefits and efficacy of the two alternatives.
A new treatment is considered to be non-inferior based
on evidence that the decrement in efficacy of the new
treatment relative to the established treatment, by a pre-
specified margin (called the “non-inferiority margin”)
[15]. For example, in a non-inferiority trial of pain man-
agement treatments such as the one conducted, if the
actual difference in mean pain intensity between IVR-
based CBT (IVR-CBT) and in-person CBT is less than
the pre-defined non-inferiority margin, IVR-CBT will be
judged to be non-inferior to in-person CBT. The pri-
mary rationale for this trial is that IVR-CBT offers
potential benefits (e.g., improved access, lower patient
burden) relative to in-person CBT, wherein the tradeoff
of a slight decrement in efficacy can be tolerated in
return for enhanced access to care. If IVR-CBT is found
to have clinically non-inferior outcomes relative to in-
person CBT, it will be recommended for use to patients
with chronic low back pain (CLBP) and could be
adopted as an alternative to the current, more costly
approach.
An important objective in translating CBT to the IVR
environment was to promote practice of the pain coping
skills through goal setting while retaining the therapist
contact and reinforcement that is associated with posi-
tive patient outcomes. We sought to leverage the ability
of the IVR system to provide brief, automated contact
with participants to not only assess skill practice adher-
ence, but to provide a sense of regular contact and to
enhance feedback.
Key intervention components
A pedometer-assisted graduated walking program
Participants in both treatment conditions are given a
pedometer to facilitate their engagement in the walking
component of the treatments. The walking program is
progressive and participants are assigned a weekly goal
of increasing their average daily step count by 10 % over
the prior week’s average step count beginning in week
three when the physical activity module is presented in
both the IVR and “live” therapist arms of the trial.
Patient handbooks
At baseline, participants in both conditions receive
handbooks that describe the CBT treatment skills and
weekly goals, and contain instructions for using the IVR
system and pedometer. For patients randomized to IVR-
CBT the handbook information is also made available
during IVR calls. Easy accessibility of this information is
critical for these patients because they cannot rely on
the therapist for its presentation and reinforcement. In
the in-person condition, information about pain coping
skills is conveyed primarily through the therapist during
weekly sessions and the companion handbook contains
shortened versions of the pain coping skill explanations
contained in the IVR-CBT handbook.
Skill practice and meaningful activity goals
Each week, participants are assigned a daily skill practice
goal that corresponds to the specific pain coping skill
presented in treatment that week (e.g., Week 4: practice
deep breathing for 5 minutes each day). The skill prac-
tice goal for each week is described in the patient hand-
book for participants randomized to the IVR-CBT
condition and is assigned by the therapist during the
weekly treatment session for participants randomized to
the in-person CBT condition. Participants in both condi-
tions are assigned the same skill practice goals (see
Table 1). As participants progress through treatment,
they are encouraged to continue practicing skills learned
in prior modules. Participants also create their own goal
for engaging in pleasant or meaningful activities to pro-
mote behavioral activation (i.e., planned rewarding or
productive activities in order to enhance mood and ac-
tivity levels). Participants in the IVR-CBT condition are
guided in this effort by information in the patient hand-
book. Participants in the in-person CBT condition col-
laborate in setting goals with their therapist during
treatment sessions.
IVR assessment
Participants in both conditions receive daily automated
calls from the IVR system. Calls are scheduled to occur
each evening at the same time within the daily assess-
ment window of 6:00 PM-10:00 PM in order to ensure
that each call represents a 24-hour reporting period.
Calls are scheduled at a time of the participant’s choos-
ing. Participants are also able to connect directly with
the Department of Veterans Affairs (VA) Veteran Crisis
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Line. The crisis line is staffed 24-hour a day and offers
callers (or those who use confidential chat or text) sup-
port, crisis response, and facilitates follow-up in-person
care at a veteran’s local VA medical center.
Weekly therapist feedback
Participants in the IVR-CBT condition receive a weekly,
two to five minute pre-recorded personalized message
from their therapist via the IVR system. On the last day
Table 1 Treatment modules and goals for CBT and IVR-CBT
Week Coping Skill Description Goals
0 None Baseline assessment None
1 Introduction Present rationale for treatment, explain
pain cycle and introduce goal setting.
- Complete one exercise each day in the “Your Guide
to Setting Meaningful Activity
Goals” section
2 Stretching Introduce stretching, its benefits, explain
acute vs. chronic pain, beliefs about pain
and provide suggested stretches to practice.
-Practice stretches provided in the handbook daily
-Set/ work on meaningful activity goal
3 Movement, Walking & Body Mechanics Instructions for walking, body mechanics,
increasing activity and preventing injuries.
-Practice body mechanics
-Increase daily steps +10 % of prior week’s steps
- Set/ work on Meaningful activity goal
-Continue to practice prior week’s skill
4 Deep Breathing Instructions for diaphragmatic breathing
and its benefits.
-Practice diaphragmatic breathing using CD for
5–10 minutes/day
-Increase daily steps +10 % of prior week’s steps
- Set/ work on meaningful activity goal
-Continue to practice prior weeks’ skills
5 Progressive Muscle Relaxation Instructions for progressive muscle
relaxation and its benefits.
-Practice progressive muscle relaxation using CD
-Increase daily steps +10 % of prior week’s steps
- Set/work on meaningful activity goal
-Continue to practice prior weeks’ skills
6 Identifying Unhealthy Thoughts Influence of negative thoughts on pain,
activities and mood.
-Practice catching unhealthy thoughts
-Increase daily steps +10 % of prior week’s steps
- Set/work on meaningful activity goal
-Continue to practice prior weeks’ skills
7 Balancing Unhealthy Thoughts Instructions for challenging and
changing negative thoughts
-Practice catching and changing unhealthy thoughts
-Increase daily steps +10 % of prior week’s steps
- Set/work on meaningful activity goal
-Continue to practice prior weeks’ skills
8 Time-Based Pacing Instructions for time-based pacing and
its benefits.
-Practice time-based pacing by applying it to one
activity daily
-Increase daily steps +10 % of prior week’s steps
- Set/work on meaningful activity goal
-Continue to practice prior weeks’ skills
9 Sleep Hygiene Common sleep problems and sleep
hygiene tips.
-Practice at least one sleep hygiene tip daily
-Increase daily steps +10 % of prior week’s steps
- Set/ work on meaningful activity goal
-Continue to practice prior weeks’ skills
10 Planning for the Future Relapse prevention; reviewing goals and
accomplishments, managing relapse and
pain flare ups.
- Complete 1 section of the pain flare prevention
handout daily.
-Increase daily steps +10 % of prior week’s steps
- Set/work on meaningful activity goal
-Continue to practice prior weeks’ skills
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of each week participants are told that they have a
message from their therapist. This message may be
accessed and replayed as often as the participants
want. If participants miss the call that contains the
feedback message, they are prompted to listen to the
message during their next call. Participants and thera-
pists may record messages to one another on the IVR
system at any time during treatment. This allows par-
ticipants and therapists to obtain clarification or feed-
back on specific topics and avoid frustration that may
impair progress or prompt dropout.
Methods/Design
This randomized controlled non-inferiority trial in-
cludes assessment of outcomes at baseline, post-
treatment (i.e., 3 months), 6 months and 9 months
(See Fig. 1) with post-treatment being the primary
timepoint. The aims of the study are:
Aim1: To determine whether IVR- CBT for chronic
low back pain is non-inferior or “not unacceptably
worse” [15] than the gold standard in-person
treatment. The primary outcome is pain intensity
as measured at post-treatment by the 11-point
[0 (no pain) to 10 (worst pain imaginable)] Numeric
Rating Scale (NRS) for pain. The non-inferiority margin
was set at one point on the NRS.
Aim 2: To determine whether IVR-CBT enhances
participants’ physical and emotional functioning,
and health-related quality of life immediately post-
treatment and each follow-up relative to in-person
treatment.
Medical record screening and advertisement
Letter to eligible patients
Eligibility screening
Does not meet eligibility 
criteria
Opts out or unable to  
contact
Ineligible or refuses to 
participate
Baseline assessment and randomization 
Post-treatment 
assessment
6 month follow-up 
assessment
9 month follow-up 
assessment
IVR-CBT CBT
Seven day assessment of pain, sleep, 
and steps via daily IVR call
IVR: Ten weekly treatment 
modules with daily IVR calls
weekly feedback via IVR
CBT: Ten individual weekly 
sessions with daily IVR calls
Post-treatment 
satisfaction interview
Fig. 1 Study recruitment, enrollment, treatment, and assessment processes
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Aim 3: To determine whether treatment groups differ
with respect to important mediators of outcomes,
including treatment dropout rates, self-reported skill
practice ratings, IVR call adherence, and treatment
satisfaction.
Aim 4: To identify key moderators of improvements in
treatment outcomes including age, sex, race/ethnicity,
number of pain sites and location, medication use, and
psychiatric comorbidities.
Eligible patients are randomized to receive either
standard in-person CBT for CLBP or IVR-CBT. This
study was approved by Institutional Review Boards at
Yale University School of Medicine and the VA
Connecticut Healthcare System (VACHS).
Eligibility
Experimental subjects and controls
Participants are 230 patients with CLBP receiving treat-
ment at the VACHS. Specific eligibility criteria include:
1) presence of at least a moderate level of pain (i.e., pain
intensity rating of ≥ 4 on the 0 to 10 NRS) for a period
of ≥ 3 months; 2) diagnosis of a low back pain condition
in the electronic health record (EHR); 3) absence of a
medical or psychiatric condition that could impair par-
ticipation (e.g., severe COPD, terminal cancer, active
substance abuse, psychosis, suicidality or severe depres-
sion Beck Depression Inventory-II score >28 ); 4) self-
reported ability to walk at least one block without chest
pain; 5) absence of dementia defined by St. Louis
University Mental Status examination (SLUMS); [16] 6)
absence of surgical interventions for pain during partici-
pation in this study (participants undergoing surgery will
be discharged from the study in order to maintain the
integrity of the active treatments); 7) availability of a
touch-tone landline or mobile telephone; and 8) absence
of any sensory deficits that would impair participation
(e.g., hearing loss to a degree that telephone usage is not
possible).
Recruitment
Participants are recruited from the VACHS by mailing
letters to those who are identified via EHR review as
having a back-pain-related diagnosis including low back
and spine conditions and nerve compression (ICD-9
codes 724.02, 724.03, 724.2, 724.3, and 724.4) and a pain
intensity rating of ≥ 4 (indicating moderate pain) [17] on
the 0–10 NRS during their most recent clinic visit.
Potential participants are called to solicit enrollment
unless an “opt out” response is received by study staff,
either by returning a pre-stamped and addressed letter
or by telephone call. Additional participants are obtained
through provider referral and advertisements placed in
clinical care areas throughout the medical center and
outpatient clinic locations of VACHS. Potential partici-
pants who respond to the referral or advertisement are
screened by the study research assistant regarding key
eligibility criteria for the study (e.g., confirmation of
presence of chronic back pain of at least moderate inten-
sity and absence of medical and psychiatric comorbidi-
ties that preclude eligibility). If initial screening suggests
potential eligibility, a face-to-face appointment is sched-
uled for obtaining written informed consent and a full
eligibility screening.
Baseline appointment
After consent, the final assessment of study eligibility is
determined through review of the EHR by the study psy-
chiatric advance practice registered nurse and psycholo-
gists, and participant responses to validated measures.
The study nurse verifies the diagnosis of CLBP and uses
a structured chart abstraction and assessment tool based
on a classification system recommended in clinical prac-
tice guidelines [18] to identify the diagnosis and treat-
ments of CLBP and classify participants’ pain as either
non-specific low back pain, low back pain with a radicu-
lar component, or pain associated with other specific
spinal causes. A trained research assistant under supervi-
sion of a psychologist reviews each participant’s chart to
identify disqualifying psychiatric diagnoses or active
suicidality. The research assistant administers a brief
semi-structured interview to collect demographic and
pain-related information, the Mini-International Neuro-
psychiatric Interview for DSM-IV (MINI) [19] to identify
the presence of any DSM-IV psychiatric disorders, the
Beck Depression Inventory-II (BDI-II) [20] to screen for
severe depressive symptoms, and the SLUMS examination
to screen for cognitive deficits likely to interfere with
treatment participation. Prescribed pain medications
and their dosage, as noted in the EHR, are recorded.
Individuals who meet eligibility criteria are enrolled in
the IVR system and TrialDB, a secure, encrypted clin-
ical trials management database that facilitates partici-
pant randomization and collection and management
of questionnaire data.
Randomization
Eligible participants are randomized to either in-person
CBT or IVR-CBT immediately after completing the
baseline assessments. The study research assistant enters
the participant’s demographic information and stratifica-
tion factors into TrialDB, which holds the randomization
schedule and is masked from users thereby enabling
concealed allocation. The treatment allocation ratio is
1:1 using a permuted stratified block design with variable
block size. Randomization is done within strata defined
by patients’ distance from the VACHS-West Haven cam-
pus (<10, 11–25, 26 or greater miles) and cause of low
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back pain as determined by the study nurse based on
EHR review (non-specific low back pain, low back pain
with a radicular component, or pain associated with
other specific spinal causes) [18]. The research assistant
informs a study therapist of the participant’s treatment
assignment.
Pedometer, TrialDB, and IVR system training
The research assistant enrolls participants in the IVR
system and TrialDB, a separate, secure, encrypted web-
interface used for completing the study outcome mea-
sures. Participants are provided with training in the use
of TrialDB, the IVR system and the study pedometer by
a brief demonstration supplemented by written instruc-
tions included in the patient handbook. Participants’
stride length is measured and they are provided with an
Omron Go Smart Model HJ-112 pocket pedometer to
use in the walking portion of the CBT and IVR-CBT
interventions.
Patient handbooks
At the end of the baseline appointment participants are
given either a CBT or IVR-CBT patient handbook.The
patient handbooks were adapted from materials used in
a prior trial of in-person CBT for CLBP by psychologists
with experience in the delivery of CBT for chronic pain
[21]. The materials are written at a 6th grade reading
level and pictures and simple figures are incorporated as
often as possible to enhance patients’ understanding and
engagement. As a check on comprehension, participants
are asked five true/false questions about each treatment
module in the week it is presented. The IVR-CBT pa-
tient handbook and IVR scripts were pilot tested with 17
individuals with chronic pain who reviewed the materials
and an additional four individuals who received treat-
ment using the new materials. Both groups provided
feedback via semi-structured interviews and revisions
were made to the materials based on feedback.
Daily IVR calls
After enrollment, but prior to beginning treatment, par-
ticipants receive seven daily IVR calls to assess their
baseline pain intensity, pedometer-measured step counts
and self-reported sleep duration in hours [22]. Starting
on the first day of treatment and continuing for 70 days,
participants receive daily IVR calls to answer seven daily
questions that assess pain intensity, sleep quality and
duration, pedometer-measured step count, catastrophiz-
ing (I worried my pain would never end”, “I felt my pain
was so bad I could not stand it anymore”) and adherence
to the current week’s skill practice goal. Once per week
participants are asked to report: 1) any adverse events
associated with the graduated walking portion of the treat-
ment, 2) any increase or decrease in pain medication dose
made on the advice of their physician or their own initia-
tive, 3) how often they practiced their weekly, self-selected
pleasant or meaningful activity goal and if it improved
their happiness or satisfaction 4) if they continued to use
any of the pain coping skills learned in prior weeks, and 5)
their comprehension of the module material via five true/
false questions about the week’s pain coping skill. All of
the information reported during a call is automatically
captured in a database and time and date stamped for
later review by a therapist. Participants receive a call at
their chosen time; if they do not complete the call, they
are called again fifteen minutes after the designated time,
and if they do not complete the second call, they are called
again one hour later. If they do not answer any of these
calls, the call day is considered missed and they are not
called again until the following day. Participants have the
option of calling into the system to make their daily report
in circumstances when they are unavailable at the sched-
uled call time. The IVR system flags any instances of a
participant missing the first call day or two consecutive
call days, and the study research assistants contact the
participant to assist them if there is a technical difficulty
or to encourage adherence to the call schedule. When par-
ticipants are unable to complete calls for an extended
period of time such as during vacation, calls can be paused
and resume when a participant returns. Participants are
not paid for completing daily IVR calls.
Treatments
Overview
Both CBT conditions include 10 treatment modules deliv-
ered over 10 consecutive weeks. Treatments are delivered
by either a PhD-level psychologist or the study nurse
trained and supervised by a clinical psychologist with spe-
cific competencies and experience in delivering CBT for
chronic pain. Therapists follow treatment manuals and
participants are provided with a treatment-specific partici-
pant handbook. The 10-week course of therapy consists of
an introductory module, followed by 8 consecutive pain
coping skills modules, and concludes with a 10th module
emphasizing skill consolidation and relapse prevention.
Both conditions include the same pain coping skills, which
were selected from a wider collection of possible skills
because they were rated most highly by participants in a
prior funded trial on importance, interest and ability to
engage in them [21] (see Table 1 for description of skills).
Participants assigned to both conditions continue to re-
ceive routine care of their CLBP by their current health-
care providers. Study staff do not attempt to influence
clinical care other than CBT in any way.
CBT involves weekly, 30-minute, individual in-person
sessions with a therapist, a pedometer-facilitated walking
program and daily IVR assessment. Each session in-
cludes one treatment module.
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Each module includes: (1) the presentation of an expli-
cit rationale for development and use of the specific cop-
ing skill being taught, (2) a description of each coping
skill, skill modeling and practice of the skill during the
session, (3) problem-solving about the practice and use
of the specific skill, and (4) assignment of a specific goal
for practice of the week’s skill and collaboration between
the therapist and participants to develop a weekly goal
for engaging in pleasant or meaningful activities.
IVR-CBT is an adapted form of in-person CBT specific-
ally designed for the IVR environment. IVR-CBT involves
reading handbook materials, a pedometer-facilitated
walking program, daily IVR assessment and retrieval
of pre-recorded therapist feedback related to treat-
ment engagement and goal completion. Participants
in the IVR-CBT condition have access to extra IVR
features not available to participants in the in-person
CBT condition. For example, optional pre-recorded,
brief audio segments are provided to reinforce the in-
formation about pain coping skills that are presented
in the patient handbook and offer participants with
poor literacy skills an additional opportunity to learn
the treatment skills. Peer testimonials feature a voice actor
speaking the words of an actual participant in one of our
prior trials of CBT for chronic pain describing their suc-
cessful use of the pain coping skills. A collection of short
motivational tips also are available.
IVR-CBT therapist feedback
Each week the therapist reviews participants’ IVR-
reported data via a web interface that summarizes the
daily reports (see Fig. 2). Therapists comment on partici-
pants’ average pain intensity, sleep, steps, and skill prac-
tice for the week and note the weekly average, any
change from the prior week, either positive or negative,
and note any patterns (e.g., more pain on weekends ver-
sus week days). Therapists also provide reinforcement
for any goal accomplishment and note potential associa-
tions among pain, goal accomplishment, and pain coping
skill practice. Therapists provide corrective feedback on
any incorrect answers to the true/false questions. Finally,
therapists assign a steps goal for the upcoming week.
Treatment fidelity measures
In-person CBT and IVR-CBT Treatment Receipt/Com-
prehension: The measures of treatment receipt (i.e., the
five- item true/false content questionnaire) have been
described above. We will analyze and report these data
regarding average level of skill comprehension and
whether any treatment modules were more difficult for
participants to understand. Treatment fidelity will be
assessed by psychologists with expertise in CBT for
chronic pain, who will rate audiotapes of 30 % of the in-
person CBT sessions and the IVR-CBT weekly feedback
recordings to assure that key components of the man-
uals are covered. Percentages of treatment integrity/vio-
lations will be calculated. The study’s psychologist
principal investigator will provide corrective feedback to
the psychologist whenever drift occurs.
Adverse events
Although walking is not considered risky for patients with
chronic musculoskeletal pain and is often recommended,
information about adverse events associated with partici-
pation in the walking portion of the treatment is solicited
once per week during the IVR assessment calls. Partici-
pants may report adverse events by recording a brief audio
message. These messages are reviewed each business day
by study staff and any reports that indicate a cause for
concern are followed-up with the participant, their pri-
mary care provider, or both.
Outcomes
Survey outcomes are assessed at 4 time points, baseline,
post-treatment, and 6 and 9 months post baseline. Par-
ticipants are given up to 14 weeks to complete treatment
in order to accommodate rescheduled sessions due to
vacations, illness or travel difficulties. Post-treatment
data are collected when a participant completes treat-
ment or at 15 weeks post-baseline regardless of whether
the participant has completed treatment. Survey out-
comes are assessed using the TrialDB system, which
allows participants to complete the self-report ques-
tionnaires online via a secure web-based interface.
Participants who do not have an Internet connection
may come to the medical center to complete the
measures via TrialDB or complete a paper version of
the measures and return them by mail. IVR outcomes
will be assessed daily during the baseline week and
over the 10 treatment weeks.
Measures were selected based on the Initiative on
Methods, Measurement and Pain Assessment in Clinical
Trials (IMMPACT) recommendations [23], which called
for the assessment of multiple domains of the pain ex-
perience in all pain treatment trials and recommended
measures based on their psychometric properties and re-
spondent burden. These measures are consistent with
CONSORT guidelines for non-inferiority trials [24] that
recommend that outcome measures be similar to those
used in studies to establish efficacy of the reference
treatment.
Primary Outcome - Pain intensity: We assess partici-
pants’ average pain intensity over the past week via sur-
vey, at the four outcome assessment points using the
Numeric Rating Scale of pain intensity (NRS-I) [25] an
11-point numeric rating scale (0 = no pain, 10 = worst
pain imaginable). The primary outcome is the average
weekly pain intensity at post-treatment.
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Secondary Outcomes – Pain intensity will also be
assessed daily during the trial via the IVR system using
the NRS scale. Subjects will have a maximum of 77 daily
scores: 7 daily calls for the baseline assessment week and
7 daily calls for each of the 10 weeks of treatment. We
will use these scores to compute weekly means for each
subject. The mean of seven daily assessments has been
found to provide reliability in excess of 0.90 [26].
Physical functioning: The nine-item Interference sub-
scale of the West Haven-Yale Multidimensional Pain
Inventory (WHYMPI) is used to assess pain-related
interference in social, work and household activities and
has demonstrated good internal consistency (.86) and
stability (.85 over 2 weeks) [27]. The 24 item Roland and
Morris Disability Questionnaire is designed to assess
physical functioning in patients with low back pain [28].
It has demonstrated good internal consistency (.84-.93)
and stability (.83 over 3 weeks) [29].
Emotional functioning: Overall emotional functioning
is assessed using the 65-item Profile of Mood States
(POMS) [30], a multidimensional measure of emotional
functioning designed to assess six dimensions of mood
and to be used in non-psychiatric or physically ill popu-
lations. Internal consistency (0.84 to 0.95, depending on
Fig. 2 Screen shots of study dashboard views
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subscale) and test-retest reliability (0.65 to 0.74, depend-
ing on subscale) is good. Depression symptom severity is
assessed using the 21-item Beck Depression Inventory-II
[31] (BDI-II) a widely used self-report measure with
excellent internal consistency (.94) and evidence of con-
vergent and discriminant validity in primary care med-
ical patients (.73–.96) [20].
Quality of Life: The Veterans SF-36 is used to assess
health-related quality of life. This measure has demon-
strated good internal consistency (.78–.93 across 8 sub-
scales) and is strongly correlated with socioeconomic
status and morbidities [32].
Tertiary outcomes
Adherence to coping skill practice is assessed via IVR.
Participants rate their daily practice of each week’s skills
on a 0 (not at all accomplished) to 10 (completely
accomplished) scale for each of the specified goals.
IVR call adherence
Call adherence is calculated as the total number of
IVR calls made divided by the total number of
expected calls (77).
Patient satisfaction
Patient satisfaction is assessed by a modified version of
the Client Satisfaction Questionnaire-8 [33], an 8-item sat-
isfaction survey designed to assess global satisfaction with
treatment. This measure has been used widely to assess
treatment satisfaction across numerous types of inter-
ventions and demonstrates good internal consistency
(α = 0.87–0.93 across three samples) and has shown
correlation to treatment attendance and retention.
Treatment attendance and drop out
Session attendance is tracked and the number of partici-
pants who do not complete follow-up assessments is cal-
culated. In order to understand reasons for treatment
dropout and evaluate “missingness” we prospectively
collect data regarding reasons for treatment dropout and
missing data. The research assistant, who monitors IVR
and questionnaire completion, collects these data.
Sample size calculation
The sample size was calculated based on a test of non-
inferiority comparing IVR-CBT to CBT, with 80 %
power, Type I error (one-sided) of 0.025, and assuming
the true difference between means is 0. Based on prelim-
inary data from similar participants in an ongoing study
of the efficacy of CBT for chronic back pain [21], the es-
timated baseline NRS pain intensity score will be 7 ±
2.45 units. A 20 % reduction in the NRS pain score from
baseline to post-treatment, that is, from 7 to 5.6 or 1.4
units, is considered to be clinically relevant. The non-
inferiority margin was set at one NRS unit, so that if the
mean pain rating for IVR-CBT is less than one unit
higher than the mean in-person CBT score (mean IVR-
CBT <mean in-person CBT + 1), IVR-CBT will be
deemed non-inferior. Conducting a test of this hypoth-
esis can be done by comparing the upper limit of the
95 % confidence interval for the mean pain difference
between IVR-CBT and in-person CBT with the non-
inferiority margin 1; if this upper limit falls below 1,
we will be able to conclude IVR-CBT is non-inferior.
Based on these assumptions and 15 % inflation for
losses, the total required sample size is 230 partici-
pants (115 per group).
Analysis plan
Baseline analysis
The adequacy of the randomization will be assessed by
comparing baseline demographic and clinical character-
istics between the two treatment groups. Additional co-
variates will include number and location of pain sites
and difference in medication use at baseline in order to
assess whether these variables are associated with a dif-
ferential response to the treatment.
Analysis
We present below the analysis of primary and secondary
outcome measures only. Analysis of primary and sec-
ondary outcomes will employ linear mixed-effects
models for longitudinal data, which will account for the
clustering induced by repeated measures on individual
patients. Mixed effects models make use of all available
measurements on subjects and provide valid infer-
ences even in the presence of missing data as long as
the missingness is at random. Data from different
subjects are assumed to be independent, while the
correlation structure of the repeated measurements
within subjects is modeled via parameterization of the
covariance structure.
Between-group comparisons of the effectiveness of
IVR-CBT and in-person CBT at each assessment time
point will be conducted. Each of these comparisons can
be tested separately within the same mixed-effect model
using a treatment dummy variable, time dummy vari-
ables, and treatment-by-time interaction terms and ap-
propriate contrasts. The outcome variable in each model
will be the outcome at the follow-up time points, with
the baseline value of the outcome and the stratification
variables included as covariates in the model. Results
will be summarized as LS- means (and their 95 % confi-
dence intervals) within and between treatment groups at
each time point. Non-inferiority will be demonstrated by
the upper limit of the 95 % confidence interval for the
LS-mean pain difference between IVR-CBT and in-
person CBT at post-treatment being less than 1.
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Following CONSORT recommendations [24], non-
inferiority analyses will be conducted both on a per
protocol (e.g., having completed 3 weeks of treatment
which is considered a dose of treatment) basis and an in-
tent-to-treat basis. All other analyses will be conducted
according to intent-to-treat basis, that is, by considering
patient group status as randomized.
Missing data
We will compare the distribution of lost patients by rea-
son between the two study groups to evaluate any differ-
ences in the reasons for losses. We will compare the rate
of loss to follow-up between the two groups using the
chi-square test, and if this rate is different between the
two groups, interpretation of the results will be made in
view of this finding. If we find any baseline variables to
be associated with the loss to follow-up, then we will in-
clude these baseline variables as covariates in the models
evaluating the intervention effect. In case of problematic
missingness, we will use multiple imputation based on
sequential regression imputation to impute missing vari-
ables. Following Rubin's method [34] for multiple imput-
ation inference, each of the simulated complete datasets
will be analyzed by standard methods, and the results
will be combined to produce estimates and confidence
intervals that incorporate missing-data uncertainty.
Discussion
To our knowledge, this study represents the first trial of
CBT for chronic pain that uses IVR as the sole means to
deliver a pain self-management intervention. Prior stud-
ies have used IVR, but only to maintain treatment effects
achieved via “live” therapy. If shown to be non-inferior
to in-person CBT in terms of efficacy, IVR-CBT could
provide an avenue for accessing empirically validated
psychological treatment for chronic pain to those who
are unable or unwilling to attend in-person treatment.
Another innovative aspect of this trial is the use of a
non-inferiority design that allows us to directly compare
the IVR-based treatment to the gold standard, in-person
CBT. Despite the recent increase in the development
and testing of technology-assisted interventions for
chronic pain and other common conditions, these treat-
ments are seldom formally compared to the in-person
treatment they seek to replace.
In addition to enhancing access to treatment, IVR may
offer advantages as a data collection method for meas-
urement of patient-reported outcomes and examining
the process of behavior change. During in-person treat-
ment, assessment of pain intensity, pain-related interfer-
ence, emotional functioning, and adherence to goals set
in prior sessions occurs during the patient’s therapy
sessions, often not immediately proximal to its occur-
rence, making the reports retrospective in nature.
Retrospective patient reporting, often using pencil and
paper methods, is the most common technique for col-
lecting information regarding a person’s pain experience
in both clinical research and treatment. Despite the
popularity and ease of use of retrospective self-reports,
this method is vulnerable to recall and cognitive biases
that attenuate their validity and reliability [35, 36].
Collecting data via a daily IVR call allows the data to be
collected prospectively, removing many of the limita-
tions of retrospective reports.
IVR-based treatment methods facilitate the collection
of daily patient-reported outcomes, which enable the
examination of treatment processes. Little is known
about the process by which people change their behavior
and obtain treatment benefits, and commonly used ana-
lytic methods do not allow the fine grained depiction of
the process of change between pre- and post-treatment,
though there have been some investigations [37, 38].
Most existing models assume that the rate of change is
constant over time, but outcomes and predictors may
change over the course of treatment. In this study the
collection of daily data over the course of 11 weeks pro-
vides high-frequency longitudinal data. These longitu-
dinal data are appropriate for analytic methods like time
varying effect models that allow us to examine change
over time in both outcomes and predictors. These mul-
tiple assessment points enhance our ability to detect the
shape of the curve associated with change and when in
the treatment process change takes place (is it constant
or does change occur primarily at a specific time during
treatment). Thus variables that are thought to affect pain
intensity like activity level, sleep, catastrophizing and
skill practice are not assumed to be constant over the
course of treatment, but are allowed to vary over time.
This will allow us to determine the change over time in
a number of factors thought to have an impact on pain
intensity and compare the process of change in treat-
ment responders (those who obtain at least a 30 %
reduction in pain intensity at post-treatment) and non-
responders.
CLBP is one of the most prevalent and costly health-
care problems in industrialized nations and a common
reason for healthcare use [1, 39]. Given the large num-
ber of individuals who could potentially benefit from
empirically validated treatments such as CBT for chronic
pain, it is important that barriers to this treatment are
addressed. An IVR-based CBT approach can be used to
enhance care for patients when face to face access is not
feasible.
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